Cochrane Abstracts
Targeted therapy for metastatic renal cell carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Targeted Therapy for Metastatic Renal Cell Carcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439174/all/Targeted_therapy_for_metastatic_renal_cell_carcinoma.
Targeted therapy for metastatic renal cell carcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439174/all/Targeted_therapy_for_metastatic_renal_cell_carcinoma. Accessed May 16, 2025.
Targeted therapy for metastatic renal cell carcinoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439174/all/Targeted_therapy_for_metastatic_renal_cell_carcinoma
Targeted Therapy for Metastatic Renal Cell Carcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439174/all/Targeted_therapy_for_metastatic_renal_cell_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Targeted therapy for metastatic renal cell carcinoma
ID - 439174
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439174/all/Targeted_therapy_for_metastatic_renal_cell_carcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
